Biomarker

May 11, 2010

Critical Path Institute’s Predictive Safety Testing Consortium Announces Special Issue of Nature Biotechnology Dedicated to Newly Qualified Kidney Safety Biomarkers

A special May 10, 2010 issue of Nature Biotechnology (NBT) includes ten scientific publications from Critical Path Institute&#8217

May 11, 2010

Urinary Biomarkers Trefoil Factor 3 and Albumin Enable Early Detection of Kidney Tubular Injury

May 11, 2010

Kidney injury Molecule-1 Outperforms Traditional Biomarkers of Kidney Injury in Preclinical Biomarker Qualification Studies

May 11, 2010

Towards Consensus Practices to Qualify Safety Biomarkers for Use in Early Drug Development

May 11, 2010

A Panel of Urinary Biomarkers to Monitor Reversibility of Renal Injury and a Serum Marker with Improved Potential to Assess Renal Function

October 5, 2010

Renal Biomarker Qualification Submission: A Dialog Between the FDA-EMEA and Predictive Safety Testing Consortium

October 5, 2010

Urinary Clusterin, Cystatin C, [beta]2-Microglobulin and Total Protein as Markers to Detect Drug-Induced Kidney Injury

May 2, 2010

Evolution of Biomarker Qualification at the Health Authorities

May 2, 2010

Next-Generation Biomarkers for Detecting Kidney Toxicity

April 2, 2010

Molecular biomarkers: a US FDA effort

Previous910 Next